Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Get an introduction to all features of this page

Microbot Medical Inc Stock

Price
Target price
€0.81

€0.81

0.560%
0.0045
0.560%
€6.40
 
25.04.24 / Frankfurt WKN: A2N5AS / Symbol: STEM / Name: Microbot Medical / Stock / Micro Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Microbot Medical Inc in the next few years
Wizard

Microbot Medical Inc Stock

The Microbot Medical Inc stock is trending slightly upwards today, with an increase of €0.005 (0.560%) compared to yesterday's price.
Currently there is a rather positive sentiment for Microbot Medical Inc with 5 Buy predictions and 0 Sell predictions.
With a target price of 6 € there is potential for a 638.92% increase which would mean more than doubling the current price of 0.81 € for Microbot Medical Inc.
So far the community has only identified positive things for Microbot Medical Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
What does Microbot Medical do?

Pros and Cons of Microbot Medical Inc in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-22

Microbot Medical Inc (NASDAQ: STEM) is a cutting-edge medical device and technology company. At a glance, it appears that the company is facing financial challenges, particularly considering its lack of revenue and consistent net losses over the years. Let's delve into a more detailed analysis to identify the potential pros and cons relating to their financials.

Growing Research & Development (R&D) expenditure: In the past three years, the R&D spending has increased, which is vital for a technology-driven company to maintain a competitive edge. The increase in R&D investment signals that the company is pushing forward with its innovation efforts in product development and working towards commercialization.

Boost in short-term investments: For fiscal year 2022, Microbot Medical increased its short-term investments to $5.76 million, up from $1.99 million in 2021 and $4.99 million in 2020. This demonstrates that the company has a good asset management strategy in place, utilizing its excess cash efficiently.

Show more

Comments

Prediction Buy
Perf. (%) -32.80%
Target price 3.687
Change
Ends at 28.02.25

Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at Susquehanna from $5.50 to $4.00. They now have a "positive" rating on the stock.
Ratings data for STEM provided by MarketBeat
Show more

Susquehanna 
0
Report Share
29.02.24
Prediction Buy
Perf. (%) -30.60%
Target price 5.510
Change
Ends at 24.01.25

Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $7.00 to $6.00. They now have a "buy" rating on the stock.
Ratings data for STEM provided by MarketBeat
Show more

The Goldman Sachs Group, Inc. 
0
Report Share
24.01.24
Prediction Buy
Perf. (%) -56.50%
Target price 11.243
Change
Ends at 06.06.24

Stem, Inc. (NYSE: STEM) is now covered by analysts at Janney Montgomery Scott. They set a "buy" rating and a $12.00 price target on the stock.
Ratings data for STEM provided by MarketBeat
Show more

Janney Montgomery Scott 
0
Report Share
06.06.23
Show more
Not a member yet? Sign up for free!